1. |
World Health Organization. Global tuberculosis report 2018. (2018-09-18)[2019-07-01]. https://www.who.int/tb/publications/global_report/en/.
|
2. |
Abel L, Fellay J, Haas DW, et al. Genetics of human susceptibility to active and latent tuberculosis: present knowledge and future perspectives. Lancet Infect Dis, 2018, 18(3): e64-e75.
|
3. |
Vasava MS, Bnoi MN, Rathwa SK, et al. Drug development against tuberculosis: past, present and future. Indian J Tuberc, 2017, 64(4): 252-275.
|
4. |
Eshiwe C, Shahi F, Gordon N, et al. Rare and unusual case of hepatic and disseminated tuberculosis in an immunocompetent patient. BMJ Case Rep, 2019, 12(6): pii: e229384.
|
5. |
Hmama Z, Peña-Díaz S, Joseph S, et al. Immunoevasion and immunosuppression of the macrophage by Mycobacterium tuberculosis. Immunol Rev, 2015, 264(1): 220-232.
|
6. |
Cai Y, Yang Q, Tang Y, et al. Increased complement C1q level marks active disease in human tuberculosis. PLoS One, 2014, 9(3): e92340.
|
7. |
Ezzie ME, Crawford M, Cho JH, et al. Gene expression networks in COPD: microRNA and mRNA regulation. Thorax, 2012, 67(2): 122-131.
|
8. |
Liu Y, Xin ZZ, Zhang DZ, et al. Transcriptome analysis of yellow catfish (Pelteobagrus fulvidraco) liver challenged with polyriboinosinic polyribocytidylic acid (poly I:C). Fish Shellfish Immunol, 2017, 68: 395-403.
|
9. |
Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Statist Soc, 1995, 57(1): 289-300.
|
10. |
Yi M, Horton JD, Cohen JC, et al. Whole pathway scope: a comprehensive pathway-based analysis tool for high-throughput data. BMC Bioinformatics, 2006, 7: 30.
|
11. |
Huang H, Zheng J, Shen N, et al. Identification of pathways and genes associated with synovitis in osteoarthritis using bioinformatics analyses. Sci Rep, 2018, 8(1): 10050.
|
12. |
Hill AV. The genomics and genetics of human infectious disease susceptibility. Ann Rev Genomics Hum Genet, 2001, 2: 373-400.
|
13. |
Casanova JL, Abel L. Genetic dissection of immunity to mycobacteria: the human model. Annu Rev Immunol, 2002, 20: 581-620.
|
14. |
Kallmann FJ, Reisner D. Twin studies on the significance of genetic factors in tuberculosis. Am Rev Tuberc, 1943, 47(6): 549-571.
|
15. |
Newport MJ, Goetghebuer T, Weis HA, et al. Genetic regulation of immune responses to vaccines in early life. Genes Immun, 2004, 5(2): 122-129.
|
16. |
Jepson A, Fowler A, Banya W, et al. Genetic regulation of acquired immune responses to antigens of Mycobacterium tuberculosis: a study of twins in West Africa. Infect Immun, 2001, 69(6): 3989-3994.
|
17. |
Crevel R, Ottenhoff TH, van der Meer JW. Innate immunity to Mycobacterium tuberculosis. Clin Microbiol Rev, 2002, 15(2): 294-309.
|
18. |
Silverstein RL, Febbraio M. CD36, a scavenger receptor involved in immunity, metabolism, angiogenesis, and behavior. Sci Signal, 2009, 2(72): re3.
|
19. |
Li C, Zhou Y, Xiang X, et al. The relationship of HLA-DQ alleles with tuberculosis risk: a meta-analysis. Lung, 2015, 193(4): 521-530.
|
20. |
Nair S, Huynh JP, Lampropoulou V, et al. Irg1 expression in myeloid cells prevents immunopathology during M. tuberculosis infection. J Exp Med, 2018, 215(4): 1035-1045.
|
21. |
Ma Y, Pang Y, Shu W, et al. Metformin reduces the relapse rate of tuberculosis patients with diabetes mellitus: experiences from 3-year follow-up. Eur J Clin Microbiol Infect Dis, 2018, 37(7): 1259-1263.
|
22. |
Brodbeck D, Cron P, Hemmings BA. A human protein kinase Bgamma with regulatory phosphorylation sites in the activation loop and in the C-terminal hydrophobic domain. J Biol Chem, 1999, 274(14): 9133-9136.
|
23. |
Manning BD, Cantley LC. AKT/PKB signaling: navigating downstream. Cell, 2007, 129(7): 1261-1274.
|
24. |
Yang ZZ, Tschoop O, Hemmings-Mieszczak M, et al. Protein kinase B alpha/Akt1 regulates placental development and fetal growth. J boil Chem, 2003, 278(34): 32124-32131.
|
25. |
Wang L, Huang D, Jiang Z, et al. Akt3 is responsible for the survival and proliferation of embryonic stem cells. Biol Open, 2017, 6(6): 850-861.
|
26. |
McElvania Tekippe E, Allen IC, Hulseberg PD, et al. Granuloma formation and host defense in chronic Mycobacterium tuberculosis infection requires PYCARD/ASC but not NLRP3 or caspase-1. PLoS One, 2010, 5(8): e12320.
|